Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium leprae | PROBABLE ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1 CLPP1 (ENDOPEPTIDASE CLP) | 0.005 | 0.2958 | 0.5639 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0024 | 0.1062 | 0.1362 |
Loa Loa (eye worm) | hypothetical protein | 0.0076 | 0.4892 | 0.4841 |
Mycobacterium leprae | ATP-dependent Clp protease proteolytic subunit 1 | 0.0026 | 0.1213 | 0.1702 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks9 | 0.0014 | 0.0293 | 0.0989 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.2274 | 0.2197 |
Echinococcus multilocularis | muscleblind protein | 0.0145 | 1 | 1 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0024 | 0.1062 | 0.359 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks5 | 0.0023 | 0.1007 | 0.3405 |
Brugia malayi | oxidoreductase, zinc-binding dehydrogenase family protein | 0.0046 | 0.2658 | 0.2317 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSD | 0.0024 | 0.1062 | 0.1362 |
Echinococcus multilocularis | peptidase Clp (S14 family) | 0.005 | 0.2958 | 0.2895 |
Echinococcus multilocularis | ATP dependent Clp protease proteolytic subunit | 0.0076 | 0.4892 | 0.4846 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0017 | 0.0548 | 0.0781 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0024 | 0.1062 | 0.1362 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSB | 0.0019 | 0.0714 | 0.0576 |
Toxoplasma gondii | ATP-dependent Clp endopeptidase, proteolytic subunit ClpP domain-containing protein | 0.0076 | 0.4892 | 1 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0024 | 0.1084 | 0.5 |
Mycobacterium ulcerans | ATP-dependent Clp protease proteolytic subunit | 0.0076 | 0.4892 | 1 |
Mycobacterium tuberculosis | Polyketide synthase Pks13 | 0.0036 | 0.1944 | 0.6571 |
Onchocerca volvulus | 0.0042 | 0.2382 | 0.9285 | |
Mycobacterium tuberculosis | Probable ATP-dependent CLP protease proteolytic subunit 2 ClpP2 (endopeptidase CLP 2) | 0.005 | 0.2958 | 1 |
Echinococcus granulosus | ATP dependent Clp protease proteolytic subunit | 0.0076 | 0.4892 | 0.4846 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSC | 0.0026 | 0.1173 | 0.1612 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSA | 0.0024 | 0.1062 | 0.1362 |
Mycobacterium leprae | PROBABLE ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 CLPP2 (ENDOPEPTIDASE CLP 2) | 0.0076 | 0.4892 | 1 |
Schistosoma mansoni | peptidase Clp (S14 family) | 0.0076 | 0.4892 | 1 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0026 | 0.1173 | 0.1612 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks7 | 0.0026 | 0.1173 | 0.3964 |
Plasmodium falciparum | ATP-dependent Clp protease proteolytic subunit | 0.0076 | 0.4892 | 1 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0024 | 0.1062 | 0.359 |
Plasmodium vivax | ATP-dependent Clp protease proteolytic subunit, putative | 0.0026 | 0.1213 | 0.0337 |
Mycobacterium leprae | Probable polyketide synthase Pks1 | 0.0026 | 0.1173 | 0.1612 |
Echinococcus granulosus | muscleblind protein | 0.0145 | 1 | 1 |
Mycobacterium ulcerans | ATP-dependent Clp protease proteolytic subunit | 0.0076 | 0.4892 | 1 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0145 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0024 | 0.1084 | 0.5 |
Mycobacterium ulcerans | multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0026 | 0.1173 | 0.1612 |
Brugia malayi | Beta-ketoacyl synthase, N-terminal domain containing protein | 0.0024 | 0.1062 | 0.0646 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0019 | 0.0714 | 0.0576 |
Brugia malayi | hypothetical protein | 0.0024 | 0.1084 | 0.067 |
Mycobacterium leprae | Polyketide synthase Pks13 | 0.0036 | 0.1944 | 0.3351 |
Plasmodium vivax | ATP-dependent Clp protease proteolytic subunit, putative | 0.0076 | 0.4892 | 1 |
Onchocerca volvulus | Fatty acid synthase homolog | 0.0043 | 0.2493 | 1 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks1 | 0.0017 | 0.056 | 0.1892 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0024 | 0.1084 | 0.1919 |
Mycobacterium leprae | Probable multifunctional mycocerosic acid synthase membrane associated enzyme Mas | 0.0026 | 0.1173 | 0.1612 |
Toxoplasma gondii | hypothetical protein | 0.0026 | 0.1213 | 0.2192 |
Toxoplasma gondii | beta-ketoacyl synthase, N-terminal domain-containing protein | 0.0016 | 0.0436 | 0.0542 |
Loa Loa (eye worm) | hypothetical protein | 0.0145 | 1 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0024 | 0.1084 | 0.5 |
Mycobacterium tuberculosis | Polyketide synthase Pks12 | 0.0026 | 0.1173 | 0.3964 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.1084 | 0.0995 |
Mycobacterium tuberculosis | Probable ATP-dependent CLP protease proteolytic subunit 1 ClpP1 (endopeptidase CLP) | 0.005 | 0.2958 | 1 |
Toxoplasma gondii | ATP-dependent Clp endopeptidase, proteolytic subunit ClpP domain-containing protein | 0.0076 | 0.4892 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0024 | 0.1084 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.0278 | 0.0181 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0024 | 0.1062 | 0.1362 |
Mycobacterium tuberculosis | Probable multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0026 | 0.1173 | 0.3964 |
Loa Loa (eye worm) | fatty acid synthase | 0.0024 | 0.1038 | 0.0949 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0024 | 0.1062 | 0.359 |
Mycobacterium tuberculosis | Probable membrane bound polyketide synthase Pks6 | 0.0036 | 0.1944 | 0.6571 |
Mycobacterium ulcerans | polyketide synthase | 0.0026 | 0.1173 | 0.1612 |
Treponema pallidum | ATP-dependent Clp protease proteolytic subunit | 0.0076 | 0.4892 | 1 |
Brugia malayi | AMP-binding enzyme family protein | 0.0023 | 0.0945 | 0.0524 |
Mycobacterium tuberculosis | Phenyloxazoline synthase MbtB (phenyloxazoline synthetase) | 0.0023 | 0.0945 | 0.3194 |
Mycobacterium tuberculosis | Polyketide synthase Pks2 | 0.0023 | 0.1007 | 0.3405 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0026 | 0.1173 | 0.2107 |
Wolbachia endosymbiont of Brugia malayi | ATP-dependent Clp protease proteolytic subunit | 0.0076 | 0.4892 | 0.5 |
Chlamydia trachomatis | ATP-dependent Clp protease proteolytic subunit | 0.0076 | 0.4892 | 0.5 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0024 | 0.1062 | 0.1362 |
Chlamydia trachomatis | ATP-dependent Clp protease proteolytic subunit | 0.0076 | 0.4892 | 0.5 |
Mycobacterium ulcerans | polyketide synthase | 0.0024 | 0.1062 | 0.1362 |
Mycobacterium ulcerans | thioesterase TesA | 0.002 | 0.0765 | 0.0692 |
Loa Loa (eye worm) | hypothetical protein | 0.0145 | 1 | 1 |
Brugia malayi | Probable ClpP-like protease | 0.0076 | 0.4892 | 0.4654 |
Mycobacterium leprae | PROBABLE THIOESTERASE TESA | 0.002 | 0.0765 | 0.0692 |
Mycobacterium tuberculosis | Probable thioesterase TesA | 0.002 | 0.0765 | 0.2585 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks8 | 0.002 | 0.0737 | 0.2492 |
Mycobacterium ulcerans | polyketide synthase Pks13 | 0.0036 | 0.1944 | 0.3351 |
Echinococcus granulosus | peptidase Clp S14 family | 0.005 | 0.2958 | 0.2895 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsB | 0.0019 | 0.0714 | 0.0576 |
Mycobacterium ulcerans | thioesterase | 0.002 | 0.0765 | 0.0692 |
Plasmodium falciparum | ATP-dependent Clp protease proteolytic subunit | 0.0026 | 0.1213 | 0.0337 |
Loa Loa (eye worm) | AMP-binding enzyme family protein | 0.0023 | 0.0945 | 0.0854 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.